Evidence for involvement of medium chain acyl-CoA dehydrogenase in the metabolism of phenylbutyrate-Reference-Cited by-同舟云学术

Evidence for involvement of medium chain acyl-CoA dehydrogenase in the metabolism of phenylbutyrate

Published:2012-12 Issue:4 Volume:107 Page:684-689
ISSN:1096-7192
Container-title:Molecular Genetics and Metabolism
language:en
Short-container-title:Molecular Genetics and Metabolism

Author:

Kormanik Kaitlyn,Kang Heejung,Cuebas Dean,Vockley Jerry,Mohsen Al-Walid

Publisher

Elsevier BV

Subject

Endocrinology,Genetics,Molecular Biology,Biochemistry,Endocrinology, Diabetes and Metabolism

Reference38 articles.

1. Impact of the putative differentiating agent sodium phenylbutyrate on myelodysplastic syndromes and acute myeloid leukemia;Gore;Clin. Cancer Res.,2001

2. Chromatin remodeling at Alu repeats by epigenetic treatment activates silenced microRNA-512-5p with downregulation of Mcl-1 in human gastric cancer cells;Saito;Oncogene,2009

3. Inhibition of histone deacetylation does not block resilencing of p16 after 5-aza-2′-deoxycytidine treatment;Egger;Cancer Res.,2007

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A multiomics approach reveals evidence for phenylbutyrate as a potential treatment for combined D,L-2- hydroxyglutaric aciduria;Molecular Genetics and Metabolism;2024-07

2. Loss of the mitochondrial citrate carrier,Slc25a1/CICdisrupts embryogenesisvia2-Hydroxyglutarate;2023-07-19

3. Treatment of neurometabolic epilepsies: Overview and recent advances;Epilepsy & Behavior;2023-05

4. Influence of the Fatty Acid Metabolism on the Mode of Action of a Cisplatin(IV) Complex with Phenylbutyrate as Axial Ligands;Pharmaceutics;2023-02-16

5. A multiomics approach to understanding pathology of Combined D,L-2- Hydroxyglutaric Aciduria and phenylbutyrate as potential treatment;2023-02-03